Jorge L. Torrecuadrada-Martinez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

A Drug-Gated, Modular STAb-T Immunotherapy With External Control.

A Drug-Gated, Modular STAb-T Immunotherapy With External Control.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 22, 2026

STAG2 cohesin cooperates with DREAM to maintain quiescence and suppress tumourigenesis in the urothelium.

STAG2 cohesin cooperates with DREAM to maintain quiescence and suppress tumourigenesis in the urothelium.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Radioimmunotheragnosis in Cancer Research.

Radioimmunotheragnosis in Cancer Research.

Journal: Cancers
Published: June 13, 2024

Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy.

Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy.

Journal: Nuclear medicine and biology
Published: April 05, 2024

Protocol for the generation and purification of high-molecular-weight covalent RNA-DNA hybrids with T4 RNA ligase.

Protocol for the generation and purification of high-molecular-weight covalent RNA-DNA hybrids with T4 RNA ligase.

Journal: STAR protocols
Published: December 12, 2023

Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging.

Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging.

Journal: Frontiers in medicine
Published: September 30, 2022

Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation.

Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation.

Journal: Molecular cell
Published: April 07, 2022

RAF1 kinase activity is dispensable for KRAS/p53 mutant lung tumor progression.

RAF1 kinase activity is dispensable for KRAS/p53 mutant lung tumor progression.

Journal: Cancer cell
Published: January 29, 2021

Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR.

Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR.

Journal: Frontiers in immunology
Published: October 05, 2020

Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas.

Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 11, 2020

EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity.

EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity.

Journal: eLife
Published: April 09, 2020

Pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one derivatives as CDK8 inhibitors.

Pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one derivatives as CDK8 inhibitors.

Journal: European journal of medicinal chemistry
Published: March 11, 2020
Showing 1-12 of 33

Last Updated: 09/26/2026